Re: Farmas USA
hombre es que despues de aprobar VVUS ya pueden aprobobar hasta los lacasitos para el dolor de cabeza...
Viendo la cotización "tan parada" de estas dos(pensaba que habría más ruleta rusa), me da tb que estará descontado ya el tema con el GAP que abra si la aprueban en apertura
edito: los de seeking ya indican como tradear con AMRN, y optimistas son algo...
Assuming FDA approval, which is widely expected, here are my scenarios for trading around AMRN post approval:
Scenario 1) FDA approval with NCE. I would expect shares to open at $21-23. Sell half and hold the rest. NCE would likely lead to an eventual buyout by a large pharmaceutical company.
Scenario 2) FDA approval; without NCE. I would expect shares to open at $18-20. Traders should be selling all shares immediately. I would likely initiate a short position on the open, expecting shares to possibly be down on the day by the close.
Scenario 3) FDA approval, no decision on NCE. I would expect shares to open $19-21. Trader will likely sell all their shares and step to the sidelines. Shares will likely drift lower, but still be up on the day.